Back to search

Article

Drug repositioning in response to COVID-19 and other challenging diseases

2024-01-31

Abstract excerpt

There are over 90 clinical trials including drug repositioning that have been initiated to get COVID-19 treatment/management. Antibiotic resistance, drug tolerance, mutation and adverse drug effects possess a great deal of setback during therapy especially with emerging infectious diseases and this necessitates the need for research into getting new drugs or repositioning the existing ones to meet up with the trea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f79d70d1-ac86-50b3-be0a-af1c7e8b2283
DOI
10.22541/au.170670501.14884284/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Drug repositioning in response to COVID-19 and other challenging diseasesDOI 10.22541/au.170670501.14884284/v1
Select a neighboring publication to make it the new centre.